Code | 5157E | ||||||||||
MA number | 29/0271/23-S | ||||||||||
Product Form: | tbl 50x300 mg (blis.PVDC/PVC/Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Medreg s.r.o., Czechia | ||||||||||
Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister PVDC/PVC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 03.01.2024 |
Validity: | 03.01.2029 |
Pediatric posology: | Yes |
PIL: | PIL_Allopurinol Medreg 300 mg_01.2024.pdf |
SPC: | SPC_Allopurinol Medreg 300 mg_08.2024.pdf |
Safety feature | Yes |
Data update: | 05.01.2024 |